| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Surgical management of perihilar cholangiocarcinoma: a Khon Kaen experience. | Narong Khuntikeo Ake Pugkhem Attapol Titapun Vajarabhongsa Bhudhisawasdi |
2014 | ||||
| 2. | Management in Perihilar Cholangiocarcinoma | อรรถพล ติตะปัญ | 2015 | ||||
| 3. | Outcome of curative resection for perihilar cholangiocarcinoma in Northeast Thailand | Titapun, A Pugkhem, A Luvira, V Srisuk, T Somintara, O Saeseow, OT Sripanuskul, A Nimboriboonporn, A Thinkhamrop, B Khuntikeo, N |
2015 | ||||
| 4. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment. | Thanee, M. Loilome, W. Techasen, A. Namwat, N. Khuntikeo, N. Titapun, A. Pairojkul, C. Saya, H. Yongvanit, P. |
2016 | ||||
| 5. | Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma. | Xurui Dai Suyanee Thongchot Hasaya Dokduang Watcharin Loilome Narong Khuntikeo Attapol Titapun Piti Ungarreevittaya Puangrat Yongvanit Anchalee Techasen Nisana Namwat |
2016 | ||||
| 6. | Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma | Patrakitkomjorn, S. Sombattheera, S. Boonsiri, P. Limpaiboon, T. Wongkham, C. Titapun, A. Proungvitaya, T. |
2017 | ||||
| 7. | MR imaging findings of a patient with isolated intrahepatic splenosis mistaken for hepatocellular carcinoma | Kulyada Somsap Nittaya Chamadol Attapol Titapun Chawalit Pairojkul Sakkarn Sangkhamanon |
2017 | ||||
| 8. | Programmed death-ligand 1 (PD-L1) expression associated with a high neutrophil/lymphocyte ratio in cholangiocarcinoma | Sangkhamanon, S Jongpairat, P Sookprasert, A Wirasorn, K Titapun, A Pugkhem, A Ungareevittaya, P Chindaprasirt, J |
2017 | ||||
| 9. | Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance | Manida Suksawat Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapon Titapun Supinda Koonmee Watcharin Loilome |
2017 | ||||
| 10. | Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool. | Jamnongkan, W. Thanan, R. Techasen, A. Namwat, N. Loilome, W. Intarawichian, P. Titapun, A. Yongvanit, P. |
2017 | ||||
| 11. | Upregulation of transferrin receptor-I induces cholangiocarcinoma progression via induction of labile iron pool | Wassana Jamnongkan Raynoo Thanan Anchalee Techasen Nisana Namwat Watcharin Loilome Piyapharom Intarawichian Attapol Titapun Puangrat Yongvanit |
2017 | ||||
| 12. | Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group. | Loilome, W. Yongvanit, P. Thongchot, S. Namwat, N. Sithithaworn, P. Boonmars, T. Koonmee, S. Titapun, A. Khuntikeo, N. Chamadol, N. Techasen, A. |
2017 | ||||
| 13. | CD44 variant-dependent redox status regulation in cholangiocarcinoma: A target for cholangiocarcinoma treatment | Malinee Thanee Watcharin Loilome Anchalee Techasen Nisana Namwat Attapon Titapun Narong Khuntikeo Shogo Okazaki Eiji Sugihara Hideyuki Saya Puangrat Yongvanit |
2018 | ||||
| 14. | Current Perspectives on Opisthorchiasis Control and Cholangiocarcinoma Detection in Southeast Asia | Khuntikeo, N. Titapun, A. Loilome, Yongvanit, P. Thinkhamrop, B. Chamadol, N. Boonmars, T. Andrews, R.H. Sithithaworn, P. |
2018 | ||||
| 15. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy | Suksawat, M Techasen, A Namwat, N Boonsong, T Titapun, A Ungarreevittaya, P Yongvanit, P Loilome, W |
2018 | ||||
| 16. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy | Techasen, A. Namwat, N. Titapun, A. Ungarreevittaya, P. Yongvanit, P. |
2018 | ||||
| 17. | Inhibitory effect of nvp-bkm120 on cholangiocarcinoma cell growth | Sureerat Padthaisong Hasaya Dokduang Supak Yothaisong Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapol Titapun Sakkarn Sangkhamanon Watcharin Loilome |
2018 | ||||
| 18. | Pan-class I PI3K inhibitor inhibits cholangiocarcinoma cell growth | Sureerat Padthaisong Hasaya Dokduang Supak Yothaisong Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapon Titapun Sakkarn Sangkhamanon Watcharin Loilome |
2018 | ||||
| 19. | Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway. | Loilome, W. Techasen, A. Thanee, M. Titapun, A. Yongvanit, P. Namwat, N. |
2018 | ||||
| 20. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated akt activity, enhancing chemosensitivity to gemcitabine | Techasen, A. Thongchot, S. Loilome, W. Thanan, R. Yongvanit, P. Titapun, A. Khuntikeo, N. Namwat, N. |
2018 | ||||
| 21. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. | Kittirat, Y Techasen, A Thongchot, S Loilome, W Thanan, R Yongvanit, P Sungkhamanon, S Titapun, A Khuntikeo, N Namwat, N |
2018 | ||||
| 22. | Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine | Yingpinyapat Kittirat Anchalee Techasen Suyanee Thongchot Watcharin Loilome Raynoo Thanan Puangrat Yongvanit Sakkarn Sungkhamanon Attapol Titapun Narong Khuntikeo Nisana Namwat |
2018 | ||||
| 23. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway. | Thanee, M. Techasen, A. Klanrit, Titapun, A. Loilome, |
2018 | ||||
| 24. | Frailty syndrome in biliary tract cancer patients: Prevalence and associated factors | Limpawattana, P Wirasorn, K Sookprasert, A Sawanyawisuth, K Titapun, A Luvira, V Khuntikeo, N Chindaprasirt, J |
2019 | ||||
| 25. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Klanrit, Phetcharaburanin, J. Khuntikeo, N. Titapun, A. Techasen, A. Loilome, |
2019 | ||||
| 26. | Periwound Challenges Improve Patient Satisfaction in Wound Care | Apinut Wongkietkachorn Palakorn Surakunprapha Attapol Titapun Nuttapone Wongkietkachorn Supawich Wongkietkachorn |
2019 | ||||
| 27. | Predictive utility of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intraductal papillary neoplasm of the bile duct | Luvira, V Kamsa-Ard, S Pugkhem, A Luvira, V Srisuk, T Titapun, A Silsirivanit, A Wongkham, S Khuntikeo, N Pairojkul, C Bhudhisawasdi, V |
2019 | ||||
| 28. | PRIMA-1 Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells. | Piyawajanusorn, C Kittirat, Y Sa-Ngiamwibool, P Titapun, A Loilome, W Namwat, N |
2019 | ||||
| 29. | PRIMA-1(MET) Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells | Titapun, A. Loilome, |
2019 | ||||
| 30. | A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients. | Khuntikeo, N. Koonmee, S. Chamadol, N. Laopaiboon, V. Titapun, A. Yongvanit, P. Loilome, Andrews, R.H. Thinkhamrop, K. Tawarungruang, C. Thinkhamrop, B. |
2020 | ||||
| 31. | A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma | Thanee, M. Namwat, N. Phetcharaburanin, J. Klanrit, P. Khuntikeo, N. Titapun, A. Loilome, W. |
2020 | ||||
| 32. | Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy | Thongchot, S. Thanee, M. Loilome, W. Techasen, A. Titapun, A. Yongvanit, P. Namwat, N. |
2020 | ||||
| 33. | Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy. | Thongchot, S Thanee, M Loilome, W Techasen, A Boonmars, T Sa-Ngiamwibool, P Titapun, A Yongvanit, P Isidoro, C Namwat, N |
2020 | ||||
| 34. | Evaluation of p53 and Its Target Gene Expression as Potential Biomarkers of Cholangiocarcinoma in Thai Patients. | Puetkasichonpasutha, J. Namwat, N. Titapun, A. Suthiphongchai, T. |
2020 | ||||
| 35. | Improving the Detection of Cholangiocarcinoma: In vitro MRI-Based Study Using Local Coils and T2 Mapping. | Narong Khuntikeo Attapol Titapun Nittaya Chamadol Wuttisak Boonphongsathien Prakasit Sa-Ngiamwibool Simon D. Taylor-Robinson Christopher A. Wadsworth Shuo Zhang Evdokia M. Kardoulaki Ian R. Young Richard Ra Syms |
2020 | ||||
| 36. | Interleukin 25 (IL-25) expression in cholangiocarcinoma. | Supakit Kaewsarabhumi Tanakorn Proungvitaya Temduang Limpaiboon Patcharaporn Tippayawat Doungdean Tummanatsakun Attapol Titapun Prakasit Sa-Ngaimwibool Siriporn Proungvitaya |
2020 | ||||
| 37. | In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines. | Hasaya Dokduang Wassana Jamnongkarn Bundit Promraksa Manida Suksawat Sureerat Padthaisong Malinee Thanee Jutarop Phetcharaburanin Nisana Namwat Sakkarn Sangkhamanon Attapol Titapun Narong Khuntikeo Poramate Klanrit Watcharin Loilome |
2020 | ||||
| 38. | In Vitro Intraductal MRI and T2 Mapping of Cholangiocarcinoma Using Catheter Coils | Khuntikeo, N Titapun, A Chamadol, N Boonphongsathien, W Sa-Ngiamwibool, P Taylor-Robinson, SD Wadsworth, CA Zhang, S Kardoulaki, EM Syms, RRA |
2020 | ||||
| 39. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma | Padthaisong, S Thanee, M Namwat, N Phetcharaburanin, J Klanrit, P Khuntikeo, N Titapun, A Sungkhamanon, S Saya, H Loilome, W |
2020 | ||||
| 40. | Re-Rising of Total Bilirubin Level after Postoperative Day 3 (The V Pattern) Predicting Liver Failure and Survival of Patients who Underwent Hepatectomy for Cholangiocarcinoma | Sawangkajohn, W. Luvira, V. Leeratanakachorn, N. Tipwaratorn, T. Theerakul, S. Jarearnrat, A. Titapun, A. Srisuk, T. Pugkhem, A. Khuntikeo, N. Bhudhisawasdi, V. Kamsa-Ard, S. |
2020 | ||||
| 41. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma. | Proungvitaya, T. Limpaiboon, T. Jusakul, A. Titapun, A. Patrakitkomjorn, S. |
2020 | ||||
| 42. | Serum IgG as a Marker for -Associated Cholangiocarcinoma Correlated with HER2 Overexpression. | Titapun, A Techasen, A Sa-Ngiamwibool, P Sithithaworn, P Luvira, V Srisuk, T Jareanrat, A Dokduang, H Loilome, W Thinkhamrop, B Khuntikeo, N |
2020 | ||||
| 43. | Serum IgG as a Marker for Opisthorchis viverrini-Associated Cholangiocarcinoma Correlated with HER2 Overexpression | Titapun, A. Techasen, A. Sithithaworn, P. Dokduang, H. Loilome, W. Thinkhamrop, B. Khuntikeo, N. |
2020 | ||||
| 44. | Cancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse | Suyanee Thongchot Chiara Vidoni Alessandra Ferraresi Watcharin Loilome Narong Khuntikeo Sakkarn Sangkhamanon Attapol Titapun Ciro Isidoro Nisana Namwat |
2021 | ||||
| 45. | Cancer‐associated fibroblast‐derived il‐6 determines unfavorable prognosis in cholangiocarcinoma by affecting autophagy‐associated chemoresponse | Thongchot, S. Loilome, W. Khuntikeo, N. Titapun, A. Namwat, N. |
2021 | ||||
| 46. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression | Thanee, M. Dokduang, H. Phetcharaburanin, J. Klanrit, P. Titapun, A. Namwat, N. Khuntikeo, N. Wangwiwatsin, A. Saya, H. Loilome, W. |
2021 | ||||
| 47. | Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma | Preawwalee Wintachai Jing Quan Lim Anchalee Techasen Worachart Lert-Itthiporn Sarinya Kongpetch Watcharin Loilome Jarin Chindaprasirt Attapol Titapun Nisana Namwat Narong Khuntikeo Apinya Jusakul |
2021 | ||||
| 48. | Diagnostic and prognostic value of circulating cell‐free dna for cholangiocarcinoma | Wintachai, P. Techasen, A. Lert-Itthiporn, W. Kongpetch, S. Loilome, W. Titapun, A. Namwat, N. Khuntikeo, N. Jusakul, A. |
2021 | ||||
| 49. | Efficacy of pre-operative portal vein embolization of biliary neoplasm before major hepatectomy | Wongwiwatchai, J. Titapun, A. Promsorn, J. |
2021 | ||||
| 50. | Establishment of a Potential Serum Biomarker Panel for the Diagnosis and Prognosis of Cholangiocarcinoma Using Decision Tree Algorithms | Kimawaha, P. Jusakul, A. Junsawang, P. Thanan, R. Titapun, A. Khuntikeo, N. Techasen, A. |
2021 | ||||
| 51. | High Levels of Serum IgG for and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection. | Titapun, A Luvira, V Srisuk, T Jareanrat, A Thanasukarn, V Thanee, M Sa-Ngiamwibool, P Padthaisong, S Duangkumpha, K Suksawat, M Loilome, W Sithithaworn, P Techasen, A Thinkhamrop, B Dzienny, A Caglayan, A Park, D Mahmud, S Khuntikeo, N |
2021 | ||||
| 52. | High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection | Titapun, A. Thanee, M. Padthaisong, S. Duangkumpha, K. Suksawat, M. Loilome, W. Sithithaworn, P. Techasen, A. Thinkhamrop, B. Khuntikeo, N. |
2021 | ||||
| 53. | Infrahepatic Inferior Vena Cava Clamping Reduces Blood Loss during Liver Transection for Cholangiocarcinoma. | Natwutpong Leeratanakachorn Vor Luvira Theerawee Tipwaratorn Suapa Theeragul Apiwat Jarearnrat Attapol Titapun Tharatip Srisuk Supot Kamsa-ard Ake Pugkhem Narong Khuntikeo Chawalit Pairojkul Vajarabhongsa Bhudhisawasdi |
2021 | ||||
| 54. | Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma | Padthaisong, S Phetcharaburanin, J Klanrit, P Li, JV Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Wangwiwatsin, A Mahalapbutr, P Loilome, W |
2021 | ||||
| 55. | Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models | Thanee, M Padthaisong, S Suksawat, M Dokduang, H Phetcharaburanin, J Klanrit, P Titapun, A Namwat, N Wangwiwatsin, A Sa-Ngiamwibool, P Khuntikeo, N Saya, H Loilome, W |
2021 | ||||
| 56. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression. | Jittima Tomacha Hasaya Dokduang Sureerat Padthaisong Nisana Namwat Poramate Klanrit Jutarop Phetcharaburanin Arporn Wangwiwatsin Tueanjit Khampitak Supinda Koonmee Attapol Titapun Apiwat Jarearnrat Narong Khuntikeo Watcharin Loilome |
2021 | ||||
| 57. | Benign Diseases Masquerading as Cholangiocarcinoma: Can we Differentiate before Surgery? | Wannasri, T. Luvira, V. Wongwattanachai, A. Titapun, A. Srisuk, T. Kamsa-Ard, S. Tipwaratorn, T. Theeragul, S. Pugkhem, A. Jarearnrat, A. Khuntikeo, N. Pairojkul, C. Bhudhisawasdi, V. |
2022 | ||||
| 58. | Bioinformatics and qPCR analyses of laminins’ cognate receptors in cholangiocarcinoma tissues reveal the integrin ITGB4 as a potential biomarker | Puetkasichonpasutha, J. Namwat, N. Titapun, A. Suthiphongchai, T. |
2022 | ||||
| 59. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles. | Suksawat, M. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Jarearnrat, A. Sangkhamanon, S. Loilome, W. |
2022 | ||||
| 60. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma | Kittirat, Y Suksawat, M Thongchot, S Padthaisong, S Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Sangkhamanon, S Titapun, A Loilome, W Saya, H Namwat, N |
2022 | ||||
| 61. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma. | Suksawat, M. Phetcharaburanin, J. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Techasen, A. Wangwiwatsin, A. Mahalapbutr, P. Loilome, W. |
2022 | ||||
| 62. | Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand | Sa-Ngiamwibool, P Aphivatanasiri, C Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Wee, A Koonmee, S |
2022 | ||||
| 63. | Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand | Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Loilome, W Wee, A Koonmee, S |
2022 | ||||
| 64. | Prognostic Significance of Growth Pattern in Predicting Outcome of -Associated Distal Cholangiocarcinoma in Thailand. | Kunprom, W Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Bamrungkit, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S |
2022 | ||||
| 65. | Prognostic Significance of Growth Pattern in Predicting Outcome of Opisthorchis viverrini-Associated Distal Cholangiocarcinoma in Thailand | Kunprom, W. Aphivatanasiri, C. Sa-Ngiamwibool, P. Sangkhamanon, S. Intarawichian, P. Bamrungkit, W. Thanee, M. Prajumwongs, P. Loilome, W. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Koonmee, S. |
2022 | ||||
| 66. | Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand. | Intarawichian, P Sangpaibool, S Prajumwongs, P Sa-Ngiamwibool, P Sangkhamanon, S Kunprom, W Thanee, M Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S Wee, A Aphivatanasiri, C |
2022 | ||||
| 67. | Serum α2,6-sialylated glycoform of serotransferrin as a glycobiomarker for diagnosis and prediction of clinical severity in cholangiocarcinoma | Kimawaha, P Thanan, R Jusakul, A Jamnongkan, W Silsirivanit, A Sa-Ngaimwibool, P Titapun, A Khuntikeo, N Sithithaworn, P Worasith, C Janthamala, S Lebrilla, CB Techasen, A |
2022 | ||||
| 68. | Accuracy of a new rapid diagnostic test for urinary antigen detection and assessment of drug treatment in opisthorchiasis. | Worasith, C Sithithaworn, J Wongphutorn, P Homwong, C Khongsukwiwat, K Techasen, A Kopolrat, KY Loilome, W Namwat, N Thinkamrop, B Tawarungruang, C Titapun, A Laha, T Andrews, RH Taylor-Robinson, SD Sithithaworn, P |
2023 | ||||
| 69. | BiTNet: Hybrid deep convolutional model for ultrasound image analysis of human biliary tract and its applications. | Intharah, T. Wiratchawa, K. Wanna, Y. Junsawang, P. |
2023 | ||||
| 70. | Clinicopathological Features of Epstein-Barr Virus-associated Intrahepatic Cholangiocarcinoma | Sa-ngiamwibool, P. Putraveephong, S. Sookprasert, A. Titapun, A. Wirasorn, K. Meesing, A. Watcharenwong, P. Twinprai, P. Chindaprasirt, J. |
2023 | ||||
| 71. | Compliance with enhanced recovery after surgery predicts long-term outcome after hepatectomy for cholangiocarcinoma. | Jongkatkorn, C Luvira, V Suwanprinya, C Piampatipan, K Leeratanakachorn, N Tipwaratorn, T Titapun, A Srisuk, T Theeragul, S Jarearnrat, A Thanasukarn, V Pugkhem, A Khuntikeo, N Pairojkul, C Kamsa-Ard, S Bhudhisawasdi, V |
2023 | ||||
| 72. | H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism. | Treeriya, R Ho, PN Titapun, A Klanrit, P Suksawat, M Kulthawatsiri, T Sirirattanakul, S Loilome, W Namwat, N Wangwiwatsin, A Chamadol, N Khuntikeo, N Phetcharaburanin, J |
2023 | ||||
| 73. | Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells. | Kulthawatsiri, T Kittirat, Y Phetcharaburanin, J Tomacha, J Promraksa, B Wangwiwatsin, A Klanrit, P Titapun, A Loilome, W Namwat, N |
2023 | ||||
| 74. | Palliative Care in Cholangiocarcinoma | Raksasataya, A Ahooja, A Krangbunkrong, V Jareanrat, A Titapun, A Khuntikeo, N |
2023 | ||||
| 75. | Predictive Factors for Post-Hepatectomy Liver Failure in Patients with Cholangiocarcinoma | Kriengkrai, W Somjaivong, B Titapun, A Wonggom, P |
2023 | ||||
| 76. | Preoperative controlling nutritional status (CONUT) score is an independent prognostic factor in cholangiocarcinoma patients treated with hepatectomy. | Titapun, A Sookprasert, A Sripanuskul, Y Watcharenwong, P Loilome, W Twinprai, P Srisuk, T Prajumwongs, P Chindaprasirt, J |
2023 | ||||
| 77. | Surgery. | Khuntikeo, N Pugkhem, A Srisuk, T Luvira, V Titapun, A Tipwaratorn, T Thanasukarn, V Klungboonkrong, V Wongwiwatchai, J |
2023 | ||||
| 78. | The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models. | Phukhum, P. Phetcharaburanin, J. Chaleekarn, K. Kittirat, Y. Kulthawatsiri, T. Namwat, N. Loilome, W. Khuntikeo, N. Titapun, A. Wangwiwatsin, A. Khampitak, T. Suksawat, M. Klanrit, P. |
2023 | ||||
| 79. | Improvement of survival outcomes of cholangiocarcinoma by ultrasonography surveillance: Multicenter retrospective cohorts. | Chamadol, N Laopaiboon, V Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Sarkhampee, P Ungpinitpong, W Khamvijite, P Chumnanua, Y Nethuwakul, N Sodarat, P Thammarit, S Techasen, A Thuanman, J Tawarungruang, C Thinkhamrop, B Sa-Ngiamwibool, P Loilome, W Prajumwongs, P Titapun, A |
2024 | ||||
| 80. | Improving postoperative survival in cholangiocarcinoma: development of surgical strategies with a screening program in the epidemic region. | Thanasukarn, V Srisuk, T Luvira, V Tipwaratorn, T Jareanrat, A Rattanarak, K Kraphunpongsakul, K Khuntikeo, N Chindaprasirt, J Sanlung, T Chamadol, N Koonmee, S Sa-Ngiamwibool, P Klanrit, P Wangwiwatsin, A Namwat, N Loilome, W Muangritdech, N Prajumwongs, P Watanabe, N Ebata, T Titapun, A |
2024 | ||||
| 81. | Intraductal magnetic resonance imaging of cholangiocarcinoma - a practical possibility. | Syms, R.R.A. Wadsworth, C.A. Kardoulaki, E. Titapun, A. Boonphongsathien, W. Sa-Ngiamwibool, P. Zhang, S. |
2024 | ||||
| 82. | Radiographic features predictive of recurrence and survival after surgical resection of perihilar cholangiocarcinoma. | Promsorn, J. Naknan, P. Sookprasert, A. Wirasorn, K. Chindaprasirt, J. Titapun, A. Intarawichian, P. Harisinghani, M. |
2024 | ||||
| 83. | Spatio-Temporal Analysis of Cholangiocarcinoma in a High Prevalence Area of Northeastern Thailand: A 10-Year Large Scale Screening Program. | Anchalee, N Thinkhamrop, K Suwannatrai, AT Titapun, A Loilome, W Kelly, M |
2024 | ||||
| 84. | Survival after Surgery among Cholangiocarcinoma Patients Comparing between Mucin Producing and Non-Mucin Producing. | Moungthard, H Thinkhamrop, K Titapun, A Thinkhamrop, B Kelly, M |
2024 | ||||
| 85. | AISIM: evaluating impacts of user interface elements of an AI assisting tool. | Wiratchawa, K Wanna, Y Junsawang, P Titapun, A Techasen, A Boonrod, A Laopaiboon, V Chamadol, N Bulathwela, S Intharah, T |
2025 | ||||
| 86. | Characterization of Patient-derived Xenograft Models of Liver Fluke-associated Cholangiocarcinoma: From Establishment to Molecular Profiling. | Dokduang, H Jarernrat, A Titapun, A Sitthirak, S Padthaisong, S Kittirat, Y Sangkamanon, S Sa-Ngiamwibool, P Wangwiwatsin, A Klanrit, P Namwat, N Jusakul, A Murakami, Y Loilome, W |
2025 | ||||
| 87. | Chemical composition and anticancer potential of water extracts derived from ground powder of Thai germinated brown rice (). | Dokduang, H Katenak, A Kittirat, Y Tomacha, J Promraksa, B Taing, L Na Nakorn, S Klanrit, P Namwat, N Titapun, A Loilome, W |
2025 | ||||
| 88. | Development of ready-to-use microtiter plates for enhanced ELISA detection of Opisthorchis viverrini antigens in urine samples. | Taron, W Jamnongkan, W Kamjanlard, C Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Namwat, N Techasen, A Titapun, A Boonmars, T Laummaunwai, P Sithithaworn, P Ngeontae, W Loilome, W |
2025 | ||||
| 89. | Differences in Characteristics and Outcome After Hepatic Resection Among Various Types of Mass-Forming Primary Liver Cancer | Wannasri, T. Luvira, V. Chakuttrikul, W. Titapun, A. Srisuk, T. Sathitkarnmanee, E. Pugkhem, A. Pairojkul, C. |
2025 | ||||
| 90. | Discovery of novel serum peptide biomarkers for cholangiocarcinoma recurrence through MALDI-TOF MS and LC-MS/MS peptidome analysis. | Thanasukarn, V Prajumwongs, P Muangritdech, N Loilome, W Namwat, N Klanrit, P Wangwiwatsin, A Charoenlappanit, S Jaresitthikunchai, J Roytrakul, S Titapun, A |
2025 | ||||
| 91. | Endobiliary radiofrequency ablation in recurrence and unresectable Perihilar cholangiocarcinoma. | Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Tipwaratorn, T Ahooja, A Loilome, W Prajumwongs, P Titapun, A |
2025 | ||||
| 92. | Establishment and genomic profiling of cholangiocarcinoma cells with functional characterization. | Jaidee, R Jusakul, A Pocasap, P Kukongviriyapan, V Senggunprai, L Prawan, A Loilome, W Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Namwat, N Chamgramol, Y Thanee, M Wichian, P Hong, JH Guan, P Heng, HL Pairojkul, C Teh, BT Kongpetch, S |
2025 | ||||
| 93. | Evaluation of HMGB1 Expression as a Clinical Biomarker for Cholangiocarcinoma. | Amontailak, S Titapun, A Jusakul, A Thanan, R Kimawaha, P Jamnongkan, W Thanee, M Sirithawat, P Haohan, S Techasen, A |
2025 | ||||
| 94. | Identification of serum metabolite biomarkers and metabolic reprogramming mechanisms to predict recurrence in cholangiocarcinoma. | Prajumwongs, P Titapun, A Thanasukarn, V Jareanrat, A Khuntikeo, N Namwat, N Klanrit, P Wangwiwatsin, A Chindaprasirt, J Koonmee, S Sa-Ngiamwibool, P Muangritdech, N Roytrakul, S Loilome, W |
2025 | ||||
| 95. | Large-scale epidemiology of opisthorchiasis in 21 provinces in Thailand based on diagnosis by fecal egg examination and urine antigen assay and analysis of risk factors for infection. | Kopolrat, KY Worasith, C Wongphutorn, P Techasen, A Eamudomkarn, C Sithithaworn, J Loilome, W Namwat, N Titapun, A Tawarungruang, C Thinkhamrop, B Futrakul, S Taylor-Robinson, SD Haswell, MR Khuntikeo, N Crellen, T Sithithaworn, P |
2025 | ||||
| 96. | Mitochondrial genomic alterations in cholangiocarcinoma cell lines. | Faipan, A Sitthirak, S Wangwiwatsin, A Namwat, N Klanrit, P Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Boulter, L Dokduang, H Loilome, W |
2025 | ||||
| 97. | Mutations in Cholangiocarcinoma: Prevalence, Prognostic Value, and G12/G13 Detection in Cell-Free DNA. | Thongyoo, P Chindaprasirt, J Aphivatanasiri, C Intarawichian, P Kunprom, W Kongpetch, S Techasen, A Loilome, W Namwat, N Titapun, A Jusakul, A |
2025 | ||||
| 98. | Serum peptide biomarkers by MALDI-TOF MS coupled with machine learning for diagnosis and classification of hepato-pancreato-biliary cancers. | Prajumwongs, P Titapun, A Thanasukarn, V Jareanrat, A Khuntikeo, N Rattanarak, K Namwat, N Klanrit, P Wangwiwatsin, A Chindaprasirt, J Koonmee, S Sa-Ngiamwibool, P Muangritdech, N Charoenlappanit, S Jaresitthikunchai, J Roytrakul, S Loilome, W |
2025 | ||||
| 99. | The genome sequence of the liver fluke (Poirier, 1886) Stiles & Hassall, 1896. | Wangwiwatsin, A Kulwong, S Phuyao, C Titapun, A Loilome, W Klanrit, P Namwat, N Sithithaworn, P Doyle, SR Berriman, M Crellen, T , , , , |
2025 | ||||
| 100. | Whole exome sequencing of multi-regions reveals tumor heterogeneity in Opisthorchis viverrini-associated cholangiocarcinoma. | Sitthirak, S Wangwiwatsin, A Jusakul, A Namwat, N Klanrit, P Dokduang, H Sa-Ngiamwibool, P Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Teh, BT Boulter, L Murakami, Y Loilome, W |
2025 | Count | 54 | 76 | 40 | 1 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Surgical management of perihilar cholangiocarcinoma: A Khon Kaen experience | Khuntikeo, N. Pugkhem, A. Titapun, A. Bhudhisawasdi, V. |
2014 |
Journal of Hepato-Biliary-Pancreatic Sciences 8 (21), pp. 521-524 |
||||||||
| 2. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment | Thanee, M. Loilome, W. Techasen, A. Namwat, N. Khuntikeo, N. Titapun, A. Pairojkul, C. Saya, H. Yongvanit, P. |
2016 |
Cancer Science (), pp. |
||||||||
| 3. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment | Thanee, M. Loilome, W. Techasen, A. Namwat, N. Khuntikeo, N. Titapun, A. Pairojkul, C. Saya, H. Yongvanit, P. |
2016 |
Cancer Science 7 (107), pp. 991-1000 |
||||||||
| 4. | Potential of selenium compounds as new anticancer agents for cholangiocarcinoma | Thongchot, S. Dokduang, H. Loilome, W. Khuntikeo, N. Titapun, A. Ungarreevittaya, P. Yongvanit, P. Techasen, A. Namwat, N. |
2016 |
Anticancer Research 11 (36), pp. 5981-5988 |
||||||||
| 5. | Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma | Patrakitkomjorn, S. Sombattheera, S. Boonsiri, P. Limpaiboon, T. Wongkham, C. Titapun, A. Proungvitaya, T. |
2017 |
Oncology Letters 4 (14), pp. 4943-4948 |
||||||||
| 6. | Programmed death-ligand 1 (PD-L1) expression associated with a high neutrophil/lymphocyte ratio in cholangiocarcinoma | Sookprasert, A. Wirasorn, K. Titapun, A. Pugkhem, A. |
2017 |
Asian Pacific Journal of Cancer Prevention 6 (18), pp. 1671-1674 |
||||||||
| 7. | Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance | Techasen, A. Namwat, N. Yongvanit, P. Khuntikeo, N. Titapun, A. Koonmee, S. Loilome, W. |
2017 |
Parasitology International 4 (66), pp. 486-493 |
||||||||
| 8. | Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool | Jamnongkan, W. Thanan, R. Techasen, A. Namwat, N. Loilome, W. Intarawichian, P. Titapun, A. Yongvanit, P. |
2017 |
Tumor Biology 7 (39), pp. 1-10 |
||||||||
| 9. | Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group | Loilome, W. Yongvanit, P. Thongchot, S. Namwat, N. Sithithaworn, P. Boonmars, T. Koonmee, S. Titapun, A. Khuntikeo, N. Chamadol, N. Techasen, A. |
2017 |
Parasitology International 4 (66), pp. 479-485 |
||||||||
| 10. | Current perspectives on opisthorchiasis control and cholangiocarcinoma detection in Southeast Asia | Khuntikeo, N. Titapun, A. Loilome, Yongvanit, P. Thinkhamrop, B. Chamadol, N. Boonmars, T. Andrews, R.H. Sithithaworn, P. |
2018 |
Frontiers in Medicine APR (5), pp. |
||||||||
| 11. | Current perspectives on opisthorchiasis control and cholangiocarcinoma detection in southeast asia | Khuntikeo, N. Titapun, A. Loilome, Yongvanit, P. Thinkhamrop, B. Chamadol, N. Boonmars, T. Andrews, R.H. Sithithaworn, P. |
2018 |
Frontiers in Medicine APR (5), pp. |
||||||||
| 12. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy | Techasen, A. Namwat, N. Titapun, A. Ungarreevittaya, P. Yongvanit, P. |
2018 |
FEBS Open Bio 4 (8), pp. 513-522 |
||||||||
| 13. | Inhibitory effect of nvp-bkm120 on cholangiocarcinoma cell growth | Dokduang, H. Yothaisong, S. Techasen, A. Yongvanit, P. Khuntikeo, N. Titapun, A. Loilome, |
2018 |
Oncology Letters 2 (16), pp. 1627-1633 |
||||||||
| 14. | Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway | Loilome, W. Techasen, A. Thanee, M. Titapun, A. Yongvanit, P. Namwat, N. |
2018 |
OncoTargets and Therapy (11), pp. 395-408 |
||||||||
| 15. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated akt activity, enhancing chemosensitivity to gemcitabine | Techasen, A. Thongchot, S. Loilome, W. Thanan, R. Yongvanit, P. Titapun, A. Khuntikeo, N. Namwat, N. |
2018 |
Oncology Letters 1 (15), pp. 347-353 |
||||||||
| 16. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the akt signaling pathway | Thanee, M. Techasen, A. Klanrit, Titapun, A. Loilome, |
2018 |
OncoTargets and Therapy (11), pp. 7019-7029 |
||||||||
| 17. | Frailty syndrome in biliary tract cancer patients: Prevalence and associated factors | Limpawattana, P. Wirasorn, K. Sookprasert, A. Sawanyawisuth, K. Titapun, A. Khuntikeo, N. Chindaprasirt, J. |
2019 |
Asian Pacific Journal of Cancer Prevention 5 (20), pp. 1497-1501 |
||||||||
| 18. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Klanrit, Phetcharaburanin, J. Khuntikeo, N. Titapun, A. Techasen, A. Loilome, |
2019 |
PLoS ONE 9 (14), pp. |
||||||||
| 19. | Periwound Challenges Improve Patient Satisfaction in Wound Care | Surakunprapha, P. Titapun, A. |
2019 |
Plastic and Reconstructive Surgery - Global Open 3 (7), pp. |
||||||||
| 20. | Predictive utility of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intraductal papillary neoplasm of the bile duct | Kamsa-Ard, S. Pugkhem, A. Luvira, V. Titapun, A. Silsirivanit, A. Wongkham, S. Khuntikeo, N. Pairojkul, C. Bhudhisawasdi, V. |
2019 |
Clinical and Experimental Hepatology 3 (5), pp. 250-255 |
||||||||
| 21. | PRIMA-1MET induces cellular senescence and apoptotic cell death in cholangiocarcinoma cells | Titapun, A. Loilome, |
2019 |
Cancer Genomics and Proteomics 6 (16), pp. 543-552 |
||||||||
| 22. | A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients | Khuntikeo, N. Koonmee, S. Chamadol, N. Laopaiboon, V. Titapun, A. Yongvanit, P. Loilome, Andrews, R.H. Thinkhamrop, K. Tawarungruang, C. Thinkhamrop, B. |
2020 |
HPB 6 (22), pp. 874-883 |
||||||||
| 23. | A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma | Thanee, M. Namwat, N. Phetcharaburanin, J. Klanrit, P. Khuntikeo, N. Titapun, A. Loilome, W. |
2020 |
BMC Cancer 1 (20), pp. |
||||||||
| 24. | Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy | Thongchot, S. Thanee, M. Loilome, W. Techasen, A. Titapun, A. Yongvanit, P. Namwat, N. |
2020 |
Journal of Traditional and Complementary Medicine 3 (10), pp. 230-235 |
||||||||
| 25. | Evaluation of p53 and its target gene expression as potential biomarkers of cholangiocarcinoma in Thai patients | Puetkasichonpasutha, J. Namwat, N. Titapun, A. Suthiphongchai, T. |
2020 |
Asian Pacific Journal of Cancer Prevention 3 (21), pp. 791-798 |
||||||||
| 26. | Interleukin 25 (Il-25) expression in cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Tippayawat, P. Titapun, A. Patrakitkomjorn, S. |
2020 |
Molecular and Clinical Oncology 6 (13), pp. 1-9 |
||||||||
| 27. | In vitro and in vivo anti-tumor effects of pan-her inhibitor varlitinib on cholangiocarcinoma cell lines | Dokduang, H. Promraksa, B. Thanee, M. Phetcharaburanin, J. Namwat, N. Titapun, A. Khuntikeo, N. Klanrit, P. Loilome, W. |
2020 |
Drug Design, Development and Therapy (14), pp. 2319-2334 |
||||||||
| 28. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma | Thanee, M. Phetcharaburanin, J. Klanrit, P. Khuntikeo, N. Titapun, A. Saya, H. Loilome, W. |
2020 |
Journal of Translational Medicine 1 (18), pp. |
||||||||
| 29. | Re-Rising of Total Bilirubin Level after Postoperative Day 3 (The V Pattern) Predicting Liver Failure and Survival of Patients who Underwent Hepatectomy for Cholangiocarcinoma | Sawangkajohn, W. Luvira, V. Leeratanakachorn, N. Tipwaratorn, T. Theerakul, S. Jarearnrat, A. Titapun, A. Srisuk, T. Pugkhem, A. Khuntikeo, N. Bhudhisawasdi, V. Kamsa-Ard, S. |
2020 |
Asian Pacific Journal of Cancer Prevention 12 (21), pp. 3573-3578 |
||||||||
| 30. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Jusakul, A. Titapun, A. Patrakitkomjorn, S. |
2020 |
Oncology Letters 1 (19), pp. 930-942 |
||||||||
| 31. | Serum IGG as a marker for opisthorchis viverrini-associated cholangiocarcinoma correlated with HER2 overexpression | Titapun, A. Techasen, A. Sithithaworn, P. Dokduang, H. Loilome, W. Thinkhamrop, B. Khuntikeo, N. |
2020 |
International Journal of General Medicine (13), pp. 1271-1283 |
||||||||
| 32. | Cancer‐associated fibroblast‐derived il‐6 determines unfavorable prognosis in cholangiocarcinoma by affecting autophagy‐associated chemoresponse | Thongchot, S. Loilome, W. Khuntikeo, N. Titapun, A. Namwat, N. |
2021 |
Cancers 9 (13), pp. |
||||||||
| 33. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression | Thanee, M. Dokduang, H. Phetcharaburanin, J. Klanrit, P. Titapun, A. Namwat, N. Khuntikeo, N. Wangwiwatsin, A. Saya, H. Loilome, W. |
2021 |
PLoS ONE 3 March (16), pp. |
||||||||
| 34. | Diagnostic and prognostic value of circulating cell‐free dna for cholangiocarcinoma | Wintachai, P. Techasen, A. Lert-Itthiporn, W. Kongpetch, S. Loilome, W. Titapun, A. Namwat, N. Khuntikeo, N. Jusakul, A. |
2021 |
Diagnostics 6 (11), pp. |
||||||||
| 35. | Efficacy of pre-operative portal vein embolization of biliary neoplasm before major hepatectomy | Wongwiwatchai, J. Titapun, A. Promsorn, J. |
2021 |
Journal of the Medical Association of Thailand 4 (104), pp. 583-590 |
||||||||
| 36. | Establishment of a potential serum biomarker panel for the diagnosis and prognosis of cholangiocarcinoma using decision tree algorithms | Kimawaha, P. Jusakul, A. Junsawang, P. Thanan, R. Titapun, A. Khuntikeo, N. Techasen, A. |
2021 |
Diagnostics 4 (11), pp. |
||||||||
| 37. | High levels of serum igg for opisthorchis viverrini and cd44 expression predict worse prognosis for cholangiocarcinoma patients after curative resection | Titapun, A. Thanee, M. Padthaisong, S. Duangkumpha, K. Suksawat, M. Loilome, W. Sithithaworn, P. Techasen, A. Thinkhamrop, B. Khuntikeo, N. |
2021 |
International Journal of General Medicine (14), pp. 2191-2204 |
||||||||
| 38. | Infrahepatic Inferior Vena Cava Clamping Reduces Blood Loss during Liver Transection for Cholangiocarcinoma | Titapun, A. Kamsa-Ard, S. Pugkhem, A. Khuntikeo, N. Pairojkul, C. Bhudhisawasdi, V. |
2021 |
International Journal of Hepatology (2021), pp. |
||||||||
| 39. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression | Dokduang, H. Padthaisong, S. Namwat, N. Klanrit, P. Phetcharaburanin, J. Wangwiwatsin, A. Khampitak, T. Koonmee, S. Titapun, A. Khuntikeo, N. Loilome, W. |
2021 |
Frontiers in Pharmacology (12), pp. |
||||||||
| 40. | Benign Diseases Masquerading as Cholangiocarcinoma: Can we Differentiate before Surgery? | Wannasri, T. Luvira, V. Wongwattanachai, A. Titapun, A. Srisuk, T. Kamsa-Ard, S. Tipwaratorn, T. Theeragul, S. Pugkhem, A. Jarearnrat, A. Khuntikeo, N. Pairojkul, C. Bhudhisawasdi, V. |
2022 |
Asian Pacific Journal of Cancer Care 4 (7), pp. 621-628 |
||||||||
| 41. | Bioinformatics and qPCR analyses of laminins’ cognate receptors in cholangiocarcinoma tissues reveal the integrin ITGB4 as a potential biomarker | Puetkasichonpasutha, J. Namwat, N. Titapun, A. Suthiphongchai, T. |
2022 |
ScienceAsia 4 (48), pp. 379-386 |
||||||||
| 42. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles | Suksawat, M. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Jarearnrat, A. Sangkhamanon, S. Loilome, W. |
2022 |
PeerJ (10), pp. |
||||||||
| 43. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma | Kittirat, Y. Suksawat, M. Thongchot, S. Padthaisong, S. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Titapun, A. Loilome, W. Saya, H. Namwat, N. |
2022 |
Frontiers in Pharmacology (13), pp. |
||||||||
| 44. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma | Suksawat, M. Phetcharaburanin, J. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Techasen, A. Wangwiwatsin, A. Mahalapbutr, P. Loilome, W. |
2022 |
Frontiers in Public Health (10), pp. |
||||||||
| 45. | Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand | Sa-Ngiamwibool, P. Aphivatanasiri, C. Sangkhamanon, S. Intarawichian, P. Kunprom, W. Thanee, M. Prajumwongs, P. Loilome, W. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Wee, A. Koonmee, S. |
2022 |
HPB 11 (24), pp. 1944-1956 |
||||||||
| 46. | Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand | Aphivatanasiri, C. Sa-ngiamwibool, P. Sangkhamanon, S. Intarawichian, P. Kunprom, W. Thanee, M. Prajumwongs, P. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Loilome, W. Wee, A. Koonmee, S. |
2022 |
Frontiers in Medicine (9), pp. |
||||||||
| 47. | Prognostic Significance of Growth Pattern in Predicting Outcome of Opisthorchis viverrini-Associated Distal Cholangiocarcinoma in Thailand | Kunprom, W. Aphivatanasiri, C. Sa-Ngiamwibool, P. Sangkhamanon, S. Intarawichian, P. Bamrungkit, W. Thanee, M. Prajumwongs, P. Loilome, W. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Koonmee, S. |
2022 |
Frontiers in Public Health (10), pp. |
||||||||
| 48. | Serum α2,6-sialylated glycoform of serotransferrin as a glycobiomarker for diagnosis and prediction of clinical severity in cholangiocarcinoma | Kimawaha, P. Thanan, R. Jusakul, A. Jamnongkan, W. Silsirivanit, A. Titapun, A. Khuntikeo, N. Sithithaworn, P. Worasith, C. Techasen, A. |
2022 |
Clinica Chimica Acta (536), pp. 142-154 |
||||||||
| 49. | BiTNet: Hybrid deep convolutional model for ultrasound image analysis of human biliary tract and its applications | Intharah, T. Wiratchawa, K. Wanna, Y. Junsawang, P. |
2023 |
Artificial Intelligence in Medicine (139), pp. |
||||||||
| 50. | Clinicopathological Features of Epstein-Barr Virus-associated Intrahepatic Cholangiocarcinoma | Sa-ngiamwibool, P. Putraveephong, S. Sookprasert, A. Titapun, A. Wirasorn, K. Meesing, A. Watcharenwong, P. Twinprai, P. Chindaprasirt, J. |
2023 |
Journal of the Medical Association of Thailand 4 (104), pp. S26-S30 |
||||||||
| 51. | Palliative Care in Cholangiocarcinoma | Raksasataya, A. Ahooja, A. Krangbunkrong, V. Jareanrat, A. Titapun, A. Khuntikeo, N. |
2023 |
Recent Results in Cancer Research (219), pp. 245-267 |
||||||||
| 52. | Predictive Factors for Post-Hepatectomy Liver Failure in Patients with Cholangiocarcinoma | Kriengkrai, W. Somjaivong, B. Titapun, A. Wonggom, P. |
2023 |
Asian Pacific Journal of Cancer Prevention 2 (24), pp. 575-580 |
||||||||
| 53. | The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models | Phukhum, P. Phetcharaburanin, J. Chaleekarn, K. Kittirat, Y. Kulthawatsiri, T. Namwat, N. Loilome, W. Khuntikeo, N. Titapun, A. Wangwiwatsin, A. Khampitak, T. Suksawat, M. Klanrit, P. |
2023 |
Scientific Reports 1 (13), pp. |
||||||||
| 54. | Intraductal magnetic resonance imaging of cholangiocarcinoma - a practical possibility | Syms, R.R.A. Wadsworth, C.A. Kardoulaki, E. Titapun, A. Boonphongsathien, W. Sa-Ngiamwibool, P. Zhang, S. |
2024 |
Frontiers in Oncology (14), pp. |
||||||||
| 55. | Radiographic features predictive of recurrence and survival after surgical resection of perihilar cholangiocarcinoma | Promsorn, J. Naknan, P. Sookprasert, A. Wirasorn, K. Chindaprasirt, J. Titapun, A. Intarawichian, P. Harisinghani, M. |
2024 |
Heliyon 7 (10), pp. |
||||||||
| 56. | Differences in Characteristics and Outcome After Hepatic Resection Among Various Types of Mass-Forming Primary Liver Cancer | Wannasri, T. Luvira, V. Chakuttrikul, W. Titapun, A. Srisuk, T. Sathitkarnmanee, E. Pugkhem, A. Pairojkul, C. |
2025 |
Indian Journal of Surgical Oncology (), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Surgical management of perihilar cholangiocarcinoma: a Khon Kaen experience. | Khuntikeo, N Pugkhem, A Titapun, A Bhudhisawasdi, V |
2014 |
Journal of hepato-biliary-pancreatic sciences 8 (21), pp. 521-4 |
|
| 2. | Outcome of curative resection for perihilar cholangiocarcinoma in Northeast Thailand. | Titapun, A Pugkhem, A Luvira, V Srisuk, T Somintara, O Saeseow, OT Sripanuskul, A Nimboriboonporn, A Thinkhamrop, B Khuntikeo, N |
2015 |
World journal of gastrointestinal oncology 12 (7), pp. 503-12 |
|
| 3. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment. | Thanee, M Loilome, W Techasen, A Sugihara, E Okazaki, S Abe, S Ueda, S Masuko, T Namwat, N Khuntikeo, N Titapun, A Pairojkul, C Saya, H Yongvanit, P |
2016 |
Cancer science 7 (107), pp. 991-1000 |
|
| 4. | Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma. | Dai, X Thongchot, S Dokduang, H Loilome, W Khuntikeo, N Titapun, A Ungarreevittaya, P Yongvanit, P Techasen, A Namwat, N |
2016 |
Anticancer research 11 (36), pp. 5981-5988 |
|
| 5. | Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group. | Silakit, R Loilome, W Yongvanit, P Thongchot, S Sithithaworn, P Boonmars, T Koonmee, S Titapun, A Khuntikeo, N Chamadol, N Techasen, A Namwat, N |
2017 |
Parasitology international 4 (66), pp. 479-485 |
|
| 6. | Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance. | Suksawat, M Techasen, A Namwat, N Yongvanit, P Khuntikeo, N Titapun, A Koonmee, S Loilome, W |
2017 |
Parasitology international 4 (66), pp. 486-493 |
|
| 7. | Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group. | Silakit, R Loilome, W Yongvanit, P Thongchot, S Sithithaworn, P Boonmars, T Koonmee, S Titapun, A Khuntikeo, N Chamadol, N Techasen, A Namwat, N |
2017 |
Parasitology international 4 (66), pp. 479-485 |
|
| 8. | Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma. | Proungvitaya, S Sombattheera, S Boonsiri, P Limpaiboon, T Wongkham, S Wongkham, C Titapun, A Proungvitaya, T |
2017 |
Oncology letters 4 (14), pp. 4943-4948 |
|
| 9. | Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool. | Jamnongkan, W Thanan, R Techasen, A Namwat, N Loilome, W Intarawichian, P Titapun, A Yongvanit, P |
2017 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 7 (39), pp. 1010428317717655 |
|
| 10. | Programmed Death-Ligand 1 (PD-L1) Expression Associated with a High Neutrophil/Lymphocyte Ratio in Cholangiocarcinoma | Sangkhamanon, S Jongpairat, P Sookprasert, A Wirasorn, K Titapun, A Pugkhem, A Ungareevittaya, P Chindaprasirt, J |
2017 |
Asian Pacific journal of cancer prevention : APJCP 6 (18), pp. 1671-1674 |
|
| 11. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. | Kittirat, Y Techasen, A Thongchot, S Loilome, W Thanan, R Yongvanit, P Sungkhamanon, S Titapun, A Khuntikeo, N Namwat, N |
2018 |
Oncology letters 1 (15), pp. 347-353 |
|
| 12. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway. | Khophai, S Thanee, M Techasen, A Namwat, N Klanrit, P Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Loilome, W |
2018 |
OncoTargets and therapy (11), pp. 7019-7029 |
|
| 13. | Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth. | Padthaisong, S Dokduang, H Yothaisong, S Techasen, A Namwat, N Yongvanit, P Khuntikeo, N Titapun, A Sangkhamanon, S Loilome, W |
2018 |
Oncology letters 2 (16), pp. 1627-1633 |
|
| 14. | Current Perspectives on Opisthorchiasis Control and Cholangiocarcinoma Detection in Southeast Asia. | Khuntikeo, N Titapun, A Loilome, W Yongvanit, P Thinkhamrop, B Chamadol, N Boonmars, T Nethanomsak, T Andrews, RH Petney, TN Sithithaworn, P |
2018 |
Frontiers in medicine (5), pp. 117 |
|
| 15. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy. | Suksawat, M Techasen, A Namwat, N Boonsong, T Titapun, A Ungarreevittaya, P Yongvanit, P Loilome, W |
2018 |
FEBS open bio 4 (8), pp. 513-522 |
|
| 16. | Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway. | Daya, M Loilome, W Techasen, A Thanee, M Sa-Ngiamwibool, P Titapun, A Yongvanit, P Namwat, N |
2018 |
OncoTargets and therapy (11), pp. 395-408 |
|
| 17. | Frailty Syndrome in Biliary Tract Cancer Patients: Prevalence and Associated Factors | Limpawattana, P Wirasorn, K Sookprasert, A Sawanyawisuth, K Titapun, A Luvira, V Khuntikeo, N Chindaprasirt, J |
2019 |
Asian Pacific journal of cancer prevention : APJCP 5 (20), pp. 1497-1501 |
|
| 18. | PRIMA-1 Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells. | Piyawajanusorn, C Kittirat, Y Sa-Ngiamwibool, P Titapun, A Loilome, W Namwat, N |
2019 |
Cancer genomics & proteomics 6 (16), pp. 543-552 |
|
| 19. | Predictive utility of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intraductal papillary neoplasm of the bile duct. | Luvira, V Kamsa-Ard, S Pugkhem, A Luvira, V Srisuk, T Titapun, A Silsirivanit, A Wongkham, S Khuntikeo, N Pairojkul, C Bhudhisawasdi, V |
2019 |
Clinical and experimental hepatology 3 (5), pp. 250-255 |
|
| 20. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues. | Suksawat, M Klanrit, P Phetcharaburanin, J Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Techasen, A Loilome, W |
2019 |
PloS one 9 (14), pp. e0222140 |
|
| 21. | Periwound Challenges Improve Patient Satisfaction in Wound Care. | Wongkietkachorn, A Surakunprapha, P Titapun, A Wongkietkachorn, N Wongkietkachorn, S |
2019 |
Plastic and reconstructive surgery. Global open 3 (7), pp. e2134 |
|
| 22. | Evaluation of p53 and Its Target Gene Expression as Potential Biomarkers of Cholangiocarcinoma in Thai Patients. | Puetkasichonpasutha, J Namwat, N Sa-Ngiamwibool, P Titapun, A Suthiphongchai, T |
2020 |
Asian Pacific journal of cancer prevention : APJCP 3 (21), pp. 791-798 |
|
| 23. | In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines. | Dokduang, H Jamnongkarn, W Promraksa, B Suksawat, M Padthaisong, S Thanee, M Phetcharaburanin, J Namwat, N Sangkhamanon, S Titapun, A Khuntikeo, N Klanrit, P Loilome, W |
2020 |
Drug design, development and therapy (14), pp. 2319-2334 |
|
| 24. | Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy. | Thongchot, S Thanee, M Loilome, W Techasen, A Boonmars, T Sa-Ngiamwibool, P Titapun, A Yongvanit, P Isidoro, C Namwat, N |
2020 |
Journal of traditional and complementary medicine 3 (10), pp. 230-235 |
|
| 25. | In Vitro Intraductal MRI and T2 Mapping of Cholangiocarcinoma Using Catheter Coils. | Khuntikeo, N Titapun, A Chamadol, N Boonphongsathien, W Sa-Ngiamwibool, P Taylor-Robinson, SD Wadsworth, CA Zhang, S Kardoulaki, EM Syms, RRA |
2020 |
Hepatic medicine : evidence and research (12), pp. 107-114 |
|
| 26. | A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma. | Padthaisong, S Thanee, M Namwat, N Phetcharaburanin, J Klanrit, P Khuntikeo, N Titapun, A Loilome, W |
2020 |
BMC cancer 1 (20), pp. 154 |
|
| 27. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma. | Padthaisong, S Thanee, M Namwat, N Phetcharaburanin, J Klanrit, P Khuntikeo, N Titapun, A Sungkhamanon, S Saya, H Loilome, W |
2020 |
Journal of translational medicine 1 (18), pp. 64 |
|
| 28. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma. | Chanakankun, R Proungvitaya, T Chua-On, D Limpaiboon, T Roytrakul, S Jusakul, A Titapun, A Jarearnrat, A Proungvitaya, S |
2020 |
Oncology letters 1 (19), pp. 930-942 |
|
| 29. | Interleukin 25 (IL-25) expression in cholangiocarcinoma. | Kaewsarabhumi, S Proungvitaya, T Limpaiboon, T Tippayawat, P Tummanatsakun, D Titapun, A Sa-Ngaimwibool, P Proungvitaya, S |
2020 |
Molecular and clinical oncology 6 (13), pp. 84 |
|
| 30. | Serum IgG as a Marker for -Associated Cholangiocarcinoma Correlated with HER2 Overexpression. | Titapun, A Techasen, A Sa-Ngiamwibool, P Sithithaworn, P Luvira, V Srisuk, T Jareanrat, A Dokduang, H Loilome, W Thinkhamrop, B Khuntikeo, N |
2020 |
International journal of general medicine (13), pp. 1271-1283 |
|
| 31. | Improving the Detection of Cholangiocarcinoma: In vitro MRI-Based Study Using Local Coils and T2 Mapping. | Khuntikeo, N Titapun, A Chamadol, N Boonphongsathien, W Sa-Ngiamwibool, P Taylor-Robinson, SD Wadsworth, CA Zhang, S Kardoulaki, EM Young, IR Syms, RRA |
2020 |
Hepatic medicine : evidence and research (12), pp. 29-39 |
|
| 32. | A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients. | Khuntikeo, N Koonmee, S Sa-Ngiamwibool, P Chamadol, N Laopaiboon, V Titapun, A Yongvanit, P Loilome, W Namwat, N Andrews, RH Petney, TN Thinkhamrop, K Chaichaya, N Tawarungruang, C Thuanman, J Thinkhamrop, B |
2020 |
HPB : the official journal of the International Hepato Pancreato Biliary Association 6 (22), pp. 874-883 |
|
| 33. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression. | Thanee, M Dokduang, H Kittirat, Y Phetcharaburanin, J Klanrit, P Titapun, A Namwat, N Khuntikeo, N Wangwiwatsin, A Saya, H Loilome, W |
2021 |
PloS one 3 (16), pp. e0245871 |
|
| 34. | Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models. | Thanee, M Padthaisong, S Suksawat, M Dokduang, H Phetcharaburanin, J Klanrit, P Titapun, A Namwat, N Wangwiwatsin, A Sa-Ngiamwibool, P Khuntikeo, N Saya, H Loilome, W |
2021 |
Cancer & metabolism 1 (9), pp. 11 |
|
| 35. | High Levels of Serum IgG for and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection. | Titapun, A Luvira, V Srisuk, T Jareanrat, A Thanasukarn, V Thanee, M Sa-Ngiamwibool, P Padthaisong, S Duangkumpha, K Suksawat, M Loilome, W Sithithaworn, P Techasen, A Thinkhamrop, B Dzienny, A Caglayan, A Park, D Mahmud, S Khuntikeo, N |
2021 |
International journal of general medicine (14), pp. 2191-2204 |
|
| 36. | Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma. | Padthaisong, S Phetcharaburanin, J Klanrit, P Li, JV Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Wangwiwatsin, A Mahalapbutr, P Loilome, W |
2021 |
Cancer & metabolism 1 (9), pp. 30 |
|
| 37. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression. | Tomacha, J Dokduang, H Padthaisong, S Namwat, N Klanrit, P Phetcharaburanin, J Wangwiwatsin, A Khampitak, T Koonmee, S Titapun, A Jarearnrat, A Khuntikeo, N Loilome, W |
2021 |
Frontiers in pharmacology (12), pp. 696961 |
|
| 38. | Infrahepatic Inferior Vena Cava Clamping Reduces Blood Loss during Liver Transection for Cholangiocarcinoma. | Leeratanakachorn, N Luvira, V Tipwaratorn, T Theeragul, S Jarearnrat, A Titapun, A Srisuk, T Kamsa-Ard, S Pugkhem, A Khuntikeo, N Pairojkul, C Bhudhisawasdi, V |
2021 |
International journal of hepatology (2021), pp. 1625717 |
|
| 39. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma. | Kittirat, Y Suksawat, M Thongchot, S Padthaisong, S Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Sangkhamanon, S Titapun, A Loilome, W Saya, H Namwat, N |
2022 |
Frontiers in pharmacology (13), pp. 897368 |
|
| 40. | Serum α2,6-sialylated glycoform of serotransferrin as a glycobiomarker for diagnosis and prediction of clinical severity in cholangiocarcinoma. | Kimawaha, P Thanan, R Jusakul, A Jamnongkan, W Silsirivanit, A Sa-Ngaimwibool, P Titapun, A Khuntikeo, N Sithithaworn, P Worasith, C Janthamala, S Lebrilla, CB Techasen, A |
2022 |
Clinica chimica acta; international journal of clinical chemistry (536), pp. 142-154 |
|
| 41. | Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand. | Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Loilome, W Wee, A Koonmee, S |
2022 |
Frontiers in medicine (9), pp. 893252 |
|
| 42. | Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand. | Sa-Ngiamwibool, P Aphivatanasiri, C Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Wee, A Koonmee, S |
2022 |
HPB : the official journal of the International Hepato Pancreato Biliary Association 11 (24), pp. 1944-1956 |
|
| 43. | Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand. | Intarawichian, P Sangpaibool, S Prajumwongs, P Sa-Ngiamwibool, P Sangkhamanon, S Kunprom, W Thanee, M Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S Wee, A Aphivatanasiri, C |
2022 |
Frontiers in oncology (12), pp. 1004220 |
|
| 44. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma. | Suksawat, M Phetcharaburanin, J Klanrit, P Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Vilayhong, V Sa-Ngiamwibool, P Techasen, A Wangwiwatsin, A Mahalapbutr, P Li, JV Loilome, W |
2022 |
Frontiers in public health (10), pp. 766023 |
|
| 45. | Prognostic Significance of Growth Pattern in Predicting Outcome of -Associated Distal Cholangiocarcinoma in Thailand. | Kunprom, W Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Bamrungkit, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S |
2022 |
Frontiers in public health (10), pp. 816028 |
|
| 46. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles. | Sitthirak, S Suksawat, M Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sangkhamanon, S Loilome, W |
2022 |
PeerJ (10), pp. e13876 |
|
| 47. | Preoperative controlling nutritional status (CONUT) score is an independent prognostic factor in cholangiocarcinoma patients treated with hepatectomy. | Titapun, A Sookprasert, A Sripanuskul, Y Watcharenwong, P Loilome, W Twinprai, P Srisuk, T Prajumwongs, P Chindaprasirt, J |
2023 |
Heliyon 10 (9), pp. e20473 |
|
| 48. | The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models. | Phukhum, P Phetcharaburanin, J Chaleekarn, K Kittirat, Y Kulthawatsiri, T Namwat, N Loilome, W Khuntikeo, N Titapun, A Wangwiwatsin, A Khampitak, T Suksawat, M Klanrit, P |
2023 |
Scientific reports 1 (13), pp. 3072 |
|
| 49. | Predictive Factors for Post-Hepatectomy Liver Failure in Patients with Cholangiocarcinoma. | Kriengkrai, W Somjaivong, B Titapun, A Wonggom, P |
2023 |
Asian Pacific journal of cancer prevention : APJCP 2 (24), pp. 575-580 |
|
| 50. | Accuracy of a new rapid diagnostic test for urinary antigen detection and assessment of drug treatment in opisthorchiasis. | Worasith, C Sithithaworn, J Wongphutorn, P Homwong, C Khongsukwiwat, K Techasen, A Kopolrat, KY Loilome, W Namwat, N Thinkamrop, B Tawarungruang, C Titapun, A Laha, T Andrews, RH Taylor-Robinson, SD Sithithaworn, P |
2023 |
Infectious diseases of poverty 1 (12), pp. 102 |
|
| 51. | Compliance with enhanced recovery after surgery predicts long-term outcome after hepatectomy for cholangiocarcinoma. | Jongkatkorn, C Luvira, V Suwanprinya, C Piampatipan, K Leeratanakachorn, N Tipwaratorn, T Titapun, A Srisuk, T Theeragul, S Jarearnrat, A Thanasukarn, V Pugkhem, A Khuntikeo, N Pairojkul, C Kamsa-Ard, S Bhudhisawasdi, V |
2023 |
World journal of gastrointestinal surgery 3 (15), pp. 362-373 |
|
| 52. | Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells. | Kulthawatsiri, T Kittirat, Y Phetcharaburanin, J Tomacha, J Promraksa, B Wangwiwatsin, A Klanrit, P Titapun, A Loilome, W Namwat, N |
2023 |
PeerJ (11), pp. e16512 |
|
| 53. | Surgery. | Khuntikeo, N Pugkhem, A Srisuk, T Luvira, V Titapun, A Tipwaratorn, T Thanasukarn, V Klungboonkrong, V Wongwiwatchai, J |
2023 |
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer (219), pp. 147-222 |
|
| 54. | Palliative Care in Cholangiocarcinoma. | Raksasataya, A Ahooja, A Krangbunkrong, V Jareanrat, A Titapun, A Khuntikeo, N |
2023 |
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer (219), pp. 245-267 |
|
| 55. | BiTNet: Hybrid deep convolutional model for ultrasound image analysis of human biliary tract and its applications. | Intharah, T Wiratchawa, K Wanna, Y Junsawang, P Titapun, A Techasen, A Boonrod, A Laopaiboon, V Chamadol, N Khuntikeo, N |
2023 |
Artificial intelligence in medicine (139), pp. 102539 |
|
| 56. | H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism. | Treeriya, R Ho, PN Titapun, A Klanrit, P Suksawat, M Kulthawatsiri, T Sirirattanakul, S Loilome, W Namwat, N Wangwiwatsin, A Chamadol, N Khuntikeo, N Phetcharaburanin, J |
2023 |
PeerJ (11), pp. e15386 |
|
| 57. | Radiographic features predictive of recurrence and survival after surgical resection of perihilar cholangiocarcinoma. | Promsorn, J Naknan, P Sookprasert, A Wirasorn, K Chindaprasirt, J Titapun, A Intarawichian, P Harisinghani, M |
2024 |
Heliyon 7 (10), pp. e28805 |
|
| 58. | Improving postoperative survival in cholangiocarcinoma: development of surgical strategies with a screening program in the epidemic region. | Thanasukarn, V Srisuk, T Luvira, V Tipwaratorn, T Jareanrat, A Rattanarak, K Kraphunpongsakul, K Khuntikeo, N Chindaprasirt, J Sanlung, T Chamadol, N Koonmee, S Sa-Ngiamwibool, P Klanrit, P Wangwiwatsin, A Namwat, N Loilome, W Muangritdech, N Prajumwongs, P Watanabe, N Ebata, T Titapun, A |
2024 |
World journal of surgical oncology 1 (22), pp. 287 |
|
| 59. | Improvement of survival outcomes of cholangiocarcinoma by ultrasonography surveillance: Multicenter retrospective cohorts. | Chamadol, N Laopaiboon, V Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Sarkhampee, P Ungpinitpong, W Khamvijite, P Chumnanua, Y Nethuwakul, N Sodarat, P Thammarit, S Techasen, A Thuanman, J Tawarungruang, C Thinkhamrop, B Sa-Ngiamwibool, P Loilome, W Prajumwongs, P Titapun, A |
2024 |
Heliyon 18 (10), pp. e38191 |
|
| 60. | Survival after Surgery among Cholangiocarcinoma Patients Comparing between Mucin Producing and Non-Mucin Producing. | Moungthard, H Thinkhamrop, K Titapun, A Thinkhamrop, B Kelly, M |
2024 |
Asian Pacific journal of cancer prevention : APJCP 6 (25), pp. 2139-2145 |
|
| 61. | Intraductal magnetic resonance imaging of cholangiocarcinoma - a practical possibility. | Syms, RRA Wadsworth, CA Kardoulaki, E Titapun, A Boonphongsathien, W Sa-Ngiamwibool, P Zhang, S Taylor-Robinson, SD Chamadol, N Loilome, W |
2024 |
Frontiers in oncology (14), pp. 1306242 |
|
| 62. | Spatio-Temporal Analysis of Cholangiocarcinoma in a High Prevalence Area of Northeastern Thailand: A 10-Year Large Scale Screening Program. | Anchalee, N Thinkhamrop, K Suwannatrai, AT Titapun, A Loilome, W Kelly, M |
2024 |
Asian Pacific journal of cancer prevention : APJCP 2 (25), pp. 537-546 |
|
| 63. | Mutations in Cholangiocarcinoma: Prevalence, Prognostic Value, and G12/G13 Detection in Cell-Free DNA. | Thongyoo, P Chindaprasirt, J Aphivatanasiri, C Intarawichian, P Kunprom, W Kongpetch, S Techasen, A Loilome, W Namwat, N Titapun, A Jusakul, A |
2025 |
Cancer genomics & proteomics 1 (22), pp. 112-126 |
|
| 64. | Serum peptide biomarkers by MALDI-TOF MS coupled with machine learning for diagnosis and classification of hepato-pancreato-biliary cancers. | Prajumwongs, P Titapun, A Thanasukarn, V Jareanrat, A Khuntikeo, N Rattanarak, K Namwat, N Klanrit, P Wangwiwatsin, A Chindaprasirt, J Koonmee, S Sa-Ngiamwibool, P Muangritdech, N Charoenlappanit, S Jaresitthikunchai, J Roytrakul, S Loilome, W |
2025 |
Scientific reports 1 (15), pp. 29169 |
|
| 65. | Endobiliary radiofrequency ablation in recurrence and unresectable Perihilar cholangiocarcinoma. | Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Tipwaratorn, T Ahooja, A Loilome, W Prajumwongs, P Titapun, A |
2025 |
BMC gastroenterology 1 (25), pp. 501 |
|
| 66. | Large-scale epidemiology of opisthorchiasis in 21 provinces in Thailand based on diagnosis by fecal egg examination and urine antigen assay and analysis of risk factors for infection. | Kopolrat, KY Worasith, C Wongphutorn, P Techasen, A Eamudomkarn, C Sithithaworn, J Loilome, W Namwat, N Titapun, A Tawarungruang, C Thinkhamrop, B Futrakul, S Taylor-Robinson, SD Haswell, MR Khuntikeo, N Crellen, T Sithithaworn, P |
2025 |
PLoS neglected tropical diseases 7 (19), pp. e0013095 |
|
| 67. | Development of ready-to-use microtiter plates for enhanced ELISA detection of Opisthorchis viverrini antigens in urine samples. | Taron, W Jamnongkan, W Kamjanlard, C Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Namwat, N Techasen, A Titapun, A Boonmars, T Laummaunwai, P Sithithaworn, P Ngeontae, W Loilome, W |
2025 |
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy (343), pp. 126589 |
|
| 68. | Mitochondrial genomic alterations in cholangiocarcinoma cell lines. | Faipan, A Sitthirak, S Wangwiwatsin, A Namwat, N Klanrit, P Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Boulter, L Dokduang, H Loilome, W |
2025 |
PloS one 6 (20), pp. e0323844 |
|
| 69. | AISIM: evaluating impacts of user interface elements of an AI assisting tool. | Wiratchawa, K Wanna, Y Junsawang, P Titapun, A Techasen, A Boonrod, A Laopaiboon, V Chamadol, N Bulathwela, S Intharah, T |
2025 |
PloS one 5 (20), pp. e0322854 |
|
| 70. | Whole exome sequencing of multi-regions reveals tumor heterogeneity in Opisthorchis viverrini-associated cholangiocarcinoma. | Sitthirak, S Wangwiwatsin, A Jusakul, A Namwat, N Klanrit, P Dokduang, H Sa-Ngiamwibool, P Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Teh, BT Boulter, L Murakami, Y Loilome, W |
2025 |
Scientific reports 1 (15), pp. 10886 |
|
| 71. | Identification of serum metabolite biomarkers and metabolic reprogramming mechanisms to predict recurrence in cholangiocarcinoma. | Prajumwongs, P Titapun, A Thanasukarn, V Jareanrat, A Khuntikeo, N Namwat, N Klanrit, P Wangwiwatsin, A Chindaprasirt, J Koonmee, S Sa-Ngiamwibool, P Muangritdech, N Roytrakul, S Loilome, W |
2025 |
Scientific reports 1 (15), pp. 12782 |
|
| 72. | Establishment and genomic profiling of cholangiocarcinoma cells with functional characterization. | Jaidee, R Jusakul, A Pocasap, P Kukongviriyapan, V Senggunprai, L Prawan, A Loilome, W Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Namwat, N Chamgramol, Y Thanee, M Wichian, P Hong, JH Guan, P Heng, HL Pairojkul, C Teh, BT Kongpetch, S |
2025 |
Scientific reports 1 (15), pp. 8621 |
|
| 73. | The genome sequence of the liver fluke (Poirier, 1886) Stiles & Hassall, 1896. | Wangwiwatsin, A Kulwong, S Phuyao, C Titapun, A Loilome, W Klanrit, P Namwat, N Sithithaworn, P Doyle, SR Berriman, M Crellen, T , , , , |
2025 |
Wellcome open research (10), pp. 1 |
|
| 74. | Characterization of Patient-derived Xenograft Models of Liver Fluke-associated Cholangiocarcinoma: From Establishment to Molecular Profiling. | Dokduang, H Jarernrat, A Titapun, A Sitthirak, S Padthaisong, S Kittirat, Y Sangkamanon, S Sa-Ngiamwibool, P Wangwiwatsin, A Klanrit, P Namwat, N Jusakul, A Murakami, Y Loilome, W |
2025 |
Anticancer research 2 (45), pp. 579-592 |
|
| 75. | Chemical composition and anticancer potential of water extracts derived from ground powder of Thai germinated brown rice (). | Dokduang, H Katenak, A Kittirat, Y Tomacha, J Promraksa, B Taing, L Na Nakorn, S Klanrit, P Namwat, N Titapun, A Loilome, W |
2025 |
Natural product research (), pp. 1-8 |
|
| 76. | Discovery of novel serum peptide biomarkers for cholangiocarcinoma recurrence through MALDI-TOF MS and LC-MS/MS peptidome analysis. | Thanasukarn, V Prajumwongs, P Muangritdech, N Loilome, W Namwat, N Klanrit, P Wangwiwatsin, A Charoenlappanit, S Jaresitthikunchai, J Roytrakul, S Titapun, A |
2025 |
Scientific reports 1 (15), pp. 2582 |
|
| 77. | Evaluation of HMGB1 Expression as a Clinical Biomarker for Cholangiocarcinoma. | Amontailak, S Titapun, A Jusakul, A Thanan, R Kimawaha, P Jamnongkan, W Thanee, M Sirithawat, P Haohan, S Techasen, A |
2025 |
Cancer genomics & proteomics 1 (22), pp. 81-89 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Surgical management of perihilar cholangiocarcinoma: a Khon Kaen experience | Narong Khuntikeo Ake Pugkhem Attapol Titapun Vajarabhongsa Bhudhisawasdi |
2014 |
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES 8.0 (21.0), pp. 521.0-524.0 |
21 | 0 | 0 | 0 | 0 | 0 | 21 | |
| 2. | Outcome of curative resection for perihilar cholangiocarcinoma in Northeast Thailand | Attapol Titapun Ake Pugkhem Vor Luvira Tharatip Srisuk Ongart Somintara O-tur Saeseow Anan Sripanuskul Anongporn Nimboriboonporn Bandit Thinkhamrop Narong Khuntikeo |
2015 |
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY 12.0 (7.0), pp. 503.0-512.0 |
14 | 0 | 0 | 0 | 0 | 0 | 14 | |
| 3. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment | Malinee Thanee Watcharin Loilome Anchalee Techasen Eiji Sugihara Shogo Okazaki Shinya Abe Shiho Ueda Takashi Masuko Nisana Namwat Narong Khuntikeo Attapol Titapun Chawalit Pairojkul Hideyuki Saya Puangrat Yongvanit |
2016 |
CANCER SCIENCE 7.0 (107.0), pp. 991.0-1000.0 |
40 | 0 | 0 | 0 | 0 | 0 | 40 | |
| 4. | Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma | Xurui Dai Suyanee Thongchot Hasaya Dokduang Watcharin Loilome Narong Khuntikeo Attapol Titapun Piti Ungarreevittaya Puangrat Yongvanit Anchalee Techasen Nisana Namwat |
2016 |
ANTICANCER RESEARCH 11.0 (36.0), pp. 5981.0-5988.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 5. | Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma | Siriporn Proungvitaya Sutthikan Sombattheera Patcharee Boonsiri Temduang Limpaiboon Sopit Wongkham Chaisiri Wongkham Attapol Titapun Tanakorn Proungvitaya |
2017 |
ONCOLOGY LETTERS 4.0 (14.0), pp. 4943.0-4948.0 |
15 | 0 | 0 | 0 | 0 | 0 | 15 | |
| 6. | MR imaging findings of a patient with isolated intrahepatic splenosis mistaken for hepatocellular carcinoma | Kulyada Somsap Nittaya Chamadol Attapol Titapun Chawalit Pairojkul Sakkarn Sangkhamanon |
2017 |
BJR CASE REPORTS 1.0 (3.0), pp. |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 7. | Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance | Manida Suksawat Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapon Titapun Supinda Koonmee Watcharin Loilome |
2017 |
PARASITOLOGY INTERNATIONAL 4.0 (66.0), pp. 486.0-493.0 |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
| 8. | Upregulation of transferrin receptor-I induces cholangiocarcinoma progression via induction of labile iron pool | Wassana Jamnongkan Raynoo Thanan Anchalee Techasen Nisana Namwat Watcharin Loilome Piyapharom Intarawichian Attapol Titapun Puangrat Yongvanit |
2017 |
TUMOR BIOLOGY 7.0 (39.0), pp. |
23 | 0 | 0 | 0 | 0 | 0 | 23 | |
| 9. | Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group | Runglawan Silakit Watcharin Loilome Puangrat Yongvanit Suyanee Thongchot Paiboon Sithithaworn Thidarut Boonmars Supinda Koonmee Attapol Titapun Narong Khuntikeo Nittaya Chamadol Anchalee Techasen Nisana Namwat |
2017 |
PARASITOLOGY INTERNATIONAL 4.0 (66.0), pp. 479.0-485.0 |
39 | 0 | 0 | 0 | 0 | 0 | 39 | |
| 10. | CD44 variant-dependent redox status regulation in cholangiocarcinoma: A target for cholangiocarcinoma treatment | Malinee Thanee Watcharin Loilome Anchalee Techasen Nisana Namwat Attapon Titapun Narong Khuntikeo Shogo Okazaki Eiji Sugihara Hideyuki Saya Puangrat Yongvanit |
2018 |
CANCER SCIENCE (109.0), pp. 37.0-37.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 11. | Current Perspectives on Opisthorchiasis Control and Cholangiocarcinoma Detection in Southeast Asia | Narong Khuntikeo Attapol Titapun Watcharin Loilome Puangrat Yongvanit Bandit Thinkhamrop Nittaya Chamadol Thidarat Boonmars Teerachai Nethanomsak Ross H. Andrews Trevor N. Petney Paiboon Sithithaworn |
2018 |
FRONTIERS IN MEDICINE (5.0), pp. |
28 | 0 | 0 | 0 | 0 | 0 | 28 | |
| 12. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy | Manida Suksawat Anchalee Techasen Nisana Namwat Thianrut Boonsong Attapol Titapun Piti Ungarreevittaya Puangrat Yongvanit Watcharin Loilome |
2018 |
FEBS OPEN BIO 4.0 (8.0), pp. 513.0-522.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 13. | Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth | Sureerat Padthaisong Hasaya Dokduang Supak Yothaisong Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapol Titapun Sakkarn Sangkhamanon Watcharin Loilome |
2018 |
ONCOLOGY LETTERS 2.0 (16.0), pp. 1627.0-1633.0 |
14 | 0 | 0 | 0 | 0 | 0 | 14 | |
| 14. | Pan-class I PI3K inhibitor inhibits cholangiocarcinoma cell growth | Sureerat Padthaisong Hasaya Dokduang Supak Yothaisong Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapon Titapun Sakkarn Sangkhamanon Watcharin Loilome |
2018 |
CANCER SCIENCE (109.0), pp. 745.0-745.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 15. | Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway | Minerva Daya Watcharin Loilome Anchalee Techasen Malinee Thanee Prakasit Sa-Ngiamwibool Attapol Titapun Puangrat Yongvanit Nisana Namwat |
2018 |
ONCOTARGETS AND THERAPY (11.0), pp. 395.0-408.0 |
18 | 0 | 0 | 0 | 0 | 0 | 18 | |
| 16. | Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine | Yingpinyapat Kittirat Anchalee Techasen Suyanee Thongchot Watcharin Loilome Raynoo Thanan Puangrat Yongvanit Sakkarn Sungkhamanon Attapol Titapun Narong Khuntikeo Nisana Namwat |
2018 |
ONCOLOGY LETTERS 1.0 (15.0), pp. 347.0-353.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 17. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway | Sasikamon Khophai Malinee Thanee Anchalee Techasen Nisana Namwat Poramate Klanrit Attapol Titapun Apiwat Jarearnrat Prakasit Sa-Ngiamwibool Watcharin Loilome |
2018 |
ONCOTARGETS AND THERAPY (11.0), pp. 7019.0-7029.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 18. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Manida Suksawat Poramate Klanrit Jutarop Phetcharaburanin Nisana Namwat Narong Khuntikeo Attapol Titapun Apiwat Jarearnrat Prakasit Sa-ngiamwibool Anchalee Techasen Watcharin Loilome |
2019 |
PLOS ONE 9.0 (14.0), pp. |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 19. | Periwound Challenges Improve Patient Satisfaction in Wound Care | Apinut Wongkietkachorn Palakorn Surakunprapha Attapol Titapun Nuttapone Wongkietkachorn Supawich Wongkietkachorn |
2019 |
PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN 3.0 (7.0), pp. |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 20. | Predictive utility of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intraductal papillary neoplasm of the bile duct | Vor Luvira Supot Kamsa-ard Ake Pugkhem Varisara Luvira Tharatip Srisuk Attapol Titapun Artit Silsirivanit Sopit Wongkham Narong Khuntikeo Chawalit Pairojkul Vajarabhongsa Bhudhisawasdi |
2019 |
CLINICAL AND EXPERIMENTAL HEPATOLOGY 3.0 (5.0), pp. 250.0-255.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 21. | PRIMA-1(MET) Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells | Chayanit Piyawajanusorn Yingpinyapat Kittirat Prakasit Sa-Ngiamwibool Attapol Titapun Watcharin Loilome Nisana Namwat |
2019 |
CANCER GENOMICS & PROTEOMICS 6.0 (16.0), pp. 543.0-552.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 22. | A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients | Narong Khuntikeo Supinda Koonmee Prakasit Sa-Ngiamwibool Nittaya Chamadol Vallop Laopaiboon Attapol Titapun Puangrat Yongvanit Watcharin Loilome Nisana Namwat Ross H. Andrews Trevor N. Petney Kavin Thinkhamrop Nathaphop Chaichaya Chaiwat Tawarungruang Jaruwan Thuanman Bandit Thinkhamrop |
2020 |
HPB 6.0 (22.0), pp. 874.0-883.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 23. | A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma | Sureerat Padthaisong Malinee Thanee Nisana Namwat Jutarop Phetcharaburanin Poramate Klanrit Narong Khuntikeo Attapol Titapun Watcharin Loilome |
2020 |
BMC CANCER 1.0 (20.0), pp. |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 24. | Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy | Suyanee Thongchot Malinee Thanee Watcharin Loilome Anchalee Techasen Thidarat Boonmars Prakasit Sa-Ngiamwibool Attapol Titapun Puangrat Yongvanit Ciro Isidoro Nisana Namwat |
2020 |
JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE 3.0 (10.0), pp. 230.0-235.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 25. | Improving the Detection of Cholangiocarcinoma: In vitro MRI-Based Study Using Local Coils and T2 Mapping | Narong Khuntikeo Attapol Titapun Nittaya Chamadol Wuttisak Boonphongsathien Prakasit Sa-Ngiamwibool Simon D. Taylor-Robinson Christopher A. Wadsworth Shuo Zhang Evdokia M. Kardoulaki Ian R. Young Richard Ra Syms |
2020 |
HEPATIC MEDICINE-EVIDENCE AND RESEARCH (12.0), pp. 29.0-39.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 26. | Interleukin 25 (IL-25) expression in cholangiocarcinoma | Supakit Kaewsarabhumi Tanakorn Proungvitaya Temduang Limpaiboon Patcharaporn Tippayawat Doungdean Tummanatsakun Attapol Titapun Prakasit Sa-Ngaimwibool Siriporn Proungvitaya |
2020 |
MOLECULAR AND CLINICAL ONCOLOGY 6.0 (13.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 27. | In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines | Hasaya Dokduang Wassana Jamnongkarn Bundit Promraksa Manida Suksawat Sureerat Padthaisong Malinee Thanee Jutarop Phetcharaburanin Nisana Namwat Sakkarn Sangkhamanon Attapol Titapun Narong Khuntikeo Poramate Klanrit Watcharin Loilome |
2020 |
DRUG DESIGN DEVELOPMENT AND THERAPY (14.0), pp. 2319.0-2334.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 28. | In Vitro Intraductal MRI and T2 Mapping of Cholangiocarcinoma Using Catheter Coils | Narong Khuntikeo Attapol Titapun Nittaya Chamadol Wuttisak Boonphongsathien Prakasit Sa-Ngiamwibool Simon D. Taylor-Robinson Christopher AWadsworth Shuo Zhang Evdokia M. Kardoulaki Richard R. A. Syms |
2020 |
HEPATIC MEDICINE-EVIDENCE AND RESEARCH (12.0), pp. 107.0-114.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 29. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma | Sureerat Padthaisong Malinee Thanee Nisana Namwat Jutarop Phetcharaburanin Poramate Klanrit Narong Khuntikeo Attapol Titapun Sakkarn Sungkhamanon Hideyuki Saya Watcharin Loilome |
2020 |
JOURNAL OF TRANSLATIONAL MEDICINE 1.0 (18.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 30. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma | Ravinnipa Chanakankun Tanakorn Proungvitaya Daraporn Chua-On Temduang Limpaiboon Sittiruk Roytrakul Apinya Jusakul Attapol Titapun Apiwat Jarearnrat Siriporn Proungvitaya |
2020 |
ONCOLOGY LETTERS 1.0 (19.0), pp. 930.0-942.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 31. | Serum IgG as a Marker for Opisthorchis viverrini-Associated Cholangiocarcinoma Correlated with HER2 Overexpression | Attapol Titapun Anchalee Techasen Prakasit Sa-Ngiamwibool Paiboon Sithithaworn Vor Luvira Tharatip Srisuk Apiwat Jareanrat Hasaya Dokduang Watcharin Loilonne Bandit Thinkhamrop Narong Khuntikeo |
2020 |
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (13.0), pp. 1271.0-1283.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 32. | Cancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse | Suyanee Thongchot Chiara Vidoni Alessandra Ferraresi Watcharin Loilome Narong Khuntikeo Sakkarn Sangkhamanon Attapol Titapun Ciro Isidoro Nisana Namwat |
2021 |
CANCERS 9.0 (13.0), pp. |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 33. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression | Malinee Thanee Hasaya Dokduang Yingpinyapat Kittirat Jutarop Phetcharaburanin Poramate Klanrit Attapol Titapun Nisana Namwat Narong Khuntikeo Arporn Wangwiwatsin Hideyuki Saya Watcharin Loilome |
2021 |
PLOS ONE 3.0 (16.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 34. | Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma | Preawwalee Wintachai Jing Quan Lim Anchalee Techasen Worachart Lert-Itthiporn Sarinya Kongpetch Watcharin Loilome Jarin Chindaprasirt Attapol Titapun Nisana Namwat Narong Khuntikeo Apinya Jusakul |
2021 |
DIAGNOSTICS 6.0 (11.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 35. | Establishment of a Potential Serum Biomarker Panel for the Diagnosis and Prognosis of Cholangiocarcinoma Using Decision Tree Algorithms | Phongsaran Kimawaha Apinya Jusakul Prem Junsawang Raynoo Thanan Attapol Titapun Narong Khuntikeo Anchalee Techasen |
2021 |
DIAGNOSTICS 4.0 (11.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 36. | High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection | Attapol Titapun Vor Luvira Tharatip Srisuk Apiwat Jareanrat Vasin Thanasukarn Malinee Thanee Prakasit Sa-Ngiamwibool Sureerat Padthaisong Kassaporn Duangkumpha Manida Suksawat Watcharin Loilome Paiboon Sithithaworn Anchalee Techasen Bandit Thinkhamrop Alexa Dzienny Ayse Caglayan David Park Simran Mahmud Narong Khuntikeo |
2021 |
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (14.0), pp. 2191.0-2204.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 37. | Infrahepatic Inferior Vena Cava Clamping Reduces Blood Loss during Liver Transection for Cholangiocarcinoma | Natwutpong Leeratanakachorn Vor Luvira Theerawee Tipwaratorn Suapa Theeragul Apiwat Jarearnrat Attapol Titapun Tharatip Srisuk Supot Kamsa-ard Ake Pugkhem Narong Khuntikeo Chawalit Pairojkul Vajarabhongsa Bhudhisawasdi |
2021 |
INTERNATIONAL JOURNAL OF HEPATOLOGY (2021.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 38. | Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma | Sureerat Padthaisong Jutarop Phetcharaburanin Poramate Klanrit Jia Li Nisana Namwat Narong Khuntikeo Attapol Titapun Apiwat Jarearnrat Arporn Wangwiwatsin Panupong Mahalapbutr Watcharin Loilome |
2021 |
CANCER & METABOLISM 1.0 (9.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 39. | Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models | Malinee Thanee Sureerat Padthaisong Manida Suksawat Hasaya Dokduang Jutarop Phetcharaburanin Poramate Klanrit Attapol Titapun Nisana Namwat Arporn Wangwiwatsin Prakasit Sa-ngiamwibool Narong Khuntikeo Hideyuki Saya Watcharin Loilome |
2021 |
CANCER & METABOLISM 1.0 (9.0), pp. |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 40. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression | Jittima Tomacha Hasaya Dokduang Sureerat Padthaisong Nisana Namwat Poramate Klanrit Jutarop Phetcharaburanin Arporn Wangwiwatsin Tueanjit Khampitak Supinda Koonmee Attapol Titapun Apiwat Jarearnrat Narong Khuntikeo Watcharin Loilome |
2021 |
FRONTIERS IN PHARMACOLOGY (12.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Management in Perihilar Cholangiocarcinoma | อรรถพล ติตะปัญ | 2015 |
Srinagarind Medical Journal (30 No 5), pp. 30-35 |
| Title | Authors | NRIIS type | Year | NRIIS Scholarship | ||
|---|---|---|---|---|---|---|
| 1. | การประยุกต์ใช้เทคนิค histoculture drug response assays ในการพยากรณ์การตอบสนองต่อการรักษาด้วยยาเคมีบำบัดในผู้ป่วยมะเร็งท่อน้ำดี |
รศ.ดร. วัชรินทร์ ลอยลม รศ.ดร. นิษณา นามวาท อ.ดร. อัญชลี เตชะเสน อ.ดร. อภิญญา จุ๊สกุล นพ. อรรถพล ติตะปัญ ม.ล. มานิดา ศุขสวัสดิ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2562 | ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม) |